⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CADL News
Candel Therapeutics, Inc. Common Stock
Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
prnewswire.com
TRIN
CADL
TRIN
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
globenewswire.com
CADL
Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine
globenewswire.com
CADL
Candel Therapeutics to Present at the SITC 2025 Annual Meeting
globenewswire.com
CADL
Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
globenewswire.com
CADL